Trials / Unknown
UnknownNCT03542721
Effect of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation
A Placebo-controlled, Randomized, Double-blind, Parallel, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 204 (estimated)
- Sponsor
- Dong-A Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the present clinical study is to evaluate the efficacy and safety of the DA-5515 (Circulan Soft Cap.) in patients with chronic fatigue symptoms due to impaired blood circulation.
Detailed description
This study is conducting to assess the efficacy and safety of the DA-5515 (Circulan Soft Cap.), which has been known to have a fatigue recovery effect due to impaired blood circulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-5515 | Crataegi ethanol extract, Garlic oil, Ginkgo leaf extract, Melissa folium extract (three times a day) |
| DRUG | Placebo of DA-5515 | Placebo (three times a day) |
Timeline
- Start date
- 2018-01-17
- Primary completion
- 2019-06-01
- Completion
- 2019-12-01
- First posted
- 2018-05-31
- Last updated
- 2018-06-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03542721. Inclusion in this directory is not an endorsement.